1. CureVac is being investigated for potential securities law violations. 2. CureVac shares will be exchanged for approximately $5.46 in BioNTech ADSs. 3. CureVac shareholders will own 4% to 6% of BioNTech post-transaction. 4. Legal firm seeks increased shareholder compensation for potential breaches. 5. Halper Sadeh LLC offers free consultations to affected shareholders.
The investigation implies potential legal challenges which can detract from investor confidence, potentially harming CVAC's stock value. Similar cases in biotech tend to result in declines during legal scrutiny.
The investigation could have significant implications for CVAC's stock price and investor confidence, suggesting a moderate to high impact likelihood.
Immediate concerns arise from the legal investigation, likely impacting stock performance until resolved, similar to past biotech cases facing legal challenges.
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
's sale to BioNTech SE. Under the terms of the proposed transaction, each CureVac share will be exchanged for approximately $5.46 in BioNTech ADSs. Upon closing of the proposed transaction, CureVac shareholders are expected to own between 4% and 6% of BioNTech. If you are a CureVac shareholder, click here to learn more about your legal rights and options.
's merger with M2i Global, Inc. Upon completion of the proposed transaction, current Volato shareholders will own approximately 10% of the combined company. If you are a Volato shareholder, click here to learn more about your rights and options.
's merger with Volato Group, Inc. Upon completion of the proposed transaction, M2i will own approximately 90% of the combined company. If you are a M2i shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
SOURCE Halper Sadeh LLP